Page 11 - Genetic Engineering News Today

Sancti Spíritus, Cuba. Dec 19 (Prensa Latina) For the first time in Cuba, Heberprot-P, a national growth factor, was successfully applied to a pediatric patient prior to a skin transplant in this central province, according to specialists.

Immusoft, a Seattle-based biotech company, has become the first to genetically engineer B cells and test them in a patient with a genetic disorder.

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

In a November article in Science magazine, journalist Rachael Zamzow informs us that many social scientists believe that every published paper should

B cells are prolific producers of antibodies, but for the first time, scientists have modified them to make other proteins to counteract a serious genetic disease.

The London Biotechnology Show aims to foster collaboration, innovation, and progress in the field of biotechnology.

By tagging zebra fish with a fluorescent gene, scientists could track how electric eel jolts transform DNA

One day, the technology could allow us to simply edit disease out of the body.

People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.

The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.